QQQ $ 474.86 $ 2.12 (0.45 %)
DIA $ 414.87 $ 2.97 (0.72 %)
SPY $ 561.82 $ 2.92 (0.52 %)
TLT $ 100.40 $ 0.27 (0.27 %)
GLD $ 238.66 $ 2.35 (0.99 %)
$ 0.0003
-- x --
-- x --
-- - --
$ 0.00 - $ 0.03
10
na
na
$ -79.46
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 osmotica-pharma-announces-rebranding-as-rvl-pharma-issues-q4-sales-outlook

Osmotica Pharmaceuticals plc (NASDAQ: OSMT) will change its name to RVL Pharmaceuticals plc and start trading under the new tic...

 osmotica-pharmaceuticals-says-q4-net-sales-for-unpeeq-targeted-to-range-from-20m-25m

Osmotica Pharmaceuticals Says Q4 Net Sales For UNPEEQ Targeted To Range From $20M-$25M

Core News & Articles

Osmotica Pharmaceuticals plc (Nasdaq: OSMT) ("OSMT" or the "Company"), a specialty pharmaceutical company, anno...

 54-biggest-movers-from-thursday
54 Biggest Movers From Thursday
12/27/2021 10:07:47

Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco pro...

 38-stocks-moving-in-thursdays-mid-day-session

Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) jumped 37.3% to $2.0182. Pasithea recently said it expanded its footprint...

 18-stocks-moving-in-thursdays-pre-market-session

Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) rose 26.5% to $1.86 in pre-market trading. Pasithea recently said it expa...

 hc-wainwright--co-initiates-coverage-on-osmotica-pharmaceuticals-with-buy-rating-announces-price-target-of-5

HC Wainwright & Co. analyst Douglas Tsao initiates coverage on Osmotica Pharmaceuticals (NASDAQ:OSMT) with a Buy rating ...

 4-penny-stocks-insiders-are-buying

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors a...

 osmotica-pharmaceuticals-q3-eps-042-misses-036-estimate-sales-220m-miss-235m-estimate

Osmotica Pharmaceuticals (NASDAQ:OSMT) reported quarterly losses of $(0.42) per share which missed the analyst consensus estima...

 earnings-scheduled-for-november-15-2021

  Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third quarter.

 the-week-ahead-in-biotech-nov-14-nov-20-biomarin-fda-decision-tapering-earnings-news-flow-conference-presentations-and-more

Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and m...

 12-health-care-stocks-moving-in-wednesdays-after-market-session

Gainers

 the-daily-biotech-pulse-allogene-sinks-on-fda-clinical-hold-takeda-gets-adcom-backing-quidel-reports-q3-covid-revenues-ipos

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...

 45-biggest-movers-from-yesterday
45 Biggest Movers From Yesterday
10/08/2021 09:38:33

Gainers Camber Energy, Inc.. (NYSE: CEI) shares surged 95.9% to close at $1.78 on Thursday after dipping over 40% on Wednesd...

 mid-afternoon-market-update-crude-oil-rises-1-new-fortress-energy-shares-spike-higher

Toward the end of trading Thursday, the Dow traded up 1.29% to 34,860.01 while the NASDAQ rose 1.47% to 14,714.54. The S&P ...

 mid-day-market-update-dow-jumps-over-500-points-osmotica-pharmaceuticals-shares-slide

Midway through trading Thursday, the Dow traded up 1.51% to 34,938.25 while the NASDAQ rose 1.64% to 14,739.43. The S&P als...

 28-stocks-moving-in-thursdays-mid-day-session

Gainers Camber Energy, Inc.. (NYSE: CEI) jumped 44.2% to $1.3102 after dipping over 40% on Wednesday. Camber Energy filed am...

 mid-morning-market-update-markets-open-higher-conagra-brands-profit-beats-views

Following the market opening Thursday, the Dow traded up 1.51% to 34,936.37 while the NASDAQ rose 1.56% to 14,728.21. The S&...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION